BIOREM Inc.
BRM.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 705.12% | 278.93% | 157.85% | 32.20% | -74.90% |
| Total Depreciation and Amortization | 111.52% | 22.95% | 3.52% | 4.59% | -38.32% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13,919.79% | 4,121.26% | 475.33% | 192.37% | -101.59% |
| Change in Net Operating Assets | -190.82% | 94.59% | -156.67% | -224.73% | 237.19% |
| Cash from Operations | 72.18% | 514.69% | 25.00% | -64.86% | 48.56% |
| Capital Expenditure | 66.41% | 9.28% | -227.32% | -164.83% | -318.80% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 66.41% | 9.28% | -227.32% | -164.83% | -318.80% |
| Total Debt Issued | -- | -200.00% | -200.00% | -- | -100.00% |
| Total Debt Repaid | 53.51% | -56.32% | -133.41% | -46.59% | -73.07% |
| Issuance of Common Stock | -100.00% | -100.00% | -100.00% | 3,350.00% | 3,350.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 51.85% | -258.94% | -336.35% | -35.15% | 83.73% |
| Foreign Exchange rate Adjustments | 119.22% | 50.73% | 101.49% | 90.40% | -1,852.07% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 508.27% | 185.48% | 6.83% | -101.90% | 82.32% |
